| scholarly article | Q13442814 |
| P50 | author | Hedvig Hricak | Q5697714 |
| Oğuz Akın | Q37842477 | ||
| Amita Shukla-Dave | Q91079106 | ||
| P2093 | author name string | Victor E Reuter | |
| James A Eastham | |||
| Jingbo Zhang | |||
| Nicole M Ishill | |||
| Lauren J Carlino | |||
| P2860 | cites work | Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 |
| Cancer statistics, 2005 | Q29617572 | ||
| Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging | Q30667043 | ||
| Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy | Q30983669 | ||
| Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis | Q31029669 | ||
| Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging | Q31459575 | ||
| Prostate specific antigen: a decade of discovery--what we have learned and where we are going | Q33690182 | ||
| Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate | Q33891698 | ||
| A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team | Q34364545 | ||
| A multi-institutional evaluation of active surveillance for low risk prostate cancer | Q34541484 | ||
| The TNM classification of prostate cancer | Q36060490 | ||
| Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging | Q36434291 | ||
| Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging | Q36591016 | ||
| Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. | Q36918551 | ||
| Multiparametric magnetic resonance imaging in prostate cancer: present and future | Q37036294 | ||
| Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings | Q37070047 | ||
| Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies | Q39425604 | ||
| The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? | Q39694955 | ||
| Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening | Q40959861 | ||
| Prospective evaluation of men with stage T1C adenocarcinoma of the prostate | Q41467242 | ||
| Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study | Q41700675 | ||
| Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging | Q41700680 | ||
| Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer | Q41715418 | ||
| Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology | Q41747212 | ||
| Cancer statistics, 2003. | Q43729872 | ||
| Cancer control with radical prostatectomy alone in 1,000 consecutive patients | Q44200641 | ||
| Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results | Q44550600 | ||
| Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution | Q46375542 | ||
| Decision analysis for treatment of early stage prostate cancer | Q47690542 | ||
| A critique of the decision analysis for clinically localized prostate cancer. | Q53655802 | ||
| The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis | Q57392760 | ||
| Cancer statistics, 1993 | Q70535113 | ||
| Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis | Q70956594 | ||
| Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer | Q71606146 | ||
| Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view | Q71927079 | ||
| Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications | Q71975828 | ||
| Prostate-specific antigen-detected prostate cancer (stage T1c): an analysis of whole-mount prostatectomy specimens | Q73477732 | ||
| Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings | Q77562480 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 425-434 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging | |
| P478 | volume | 253 |
| Q37876681 | A decade in prostate cancer: from NMR to metabolomics |
| Q41911906 | A prospective study of the efficacy of magnetic resonance spectroscopy imaging for predicting locally advanced prostate cancer |
| Q42868468 | Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension? |
| Q33590993 | Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology |
| Q33773599 | Correlation of magnetic resonance imaging tumor volume with histopathology |
| Q34153708 | Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy |
| Q33933490 | Evolution from active surveillance to focal therapy in the management of prostate cancer. |
| Q37768170 | Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer |
| Q33692918 | Focal therapy in prostate cancer: modalities, findings and future considerations. |
| Q36979944 | Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview |
| Q41275019 | Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy |
| Q27002672 | MRI of localized prostate cancer: coming of age in the PSA era |
| Q41686096 | Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer |
| Q38489794 | Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis |
| Q37937948 | Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. |
| Q46012032 | Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology. |
| Q38212715 | Multiparametric MRI in prostate cancer management. |
| Q36346204 | Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study |
| Q36532680 | Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer |
| Q35722781 | Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer |
| Q52665654 | Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection. |
| Q34341015 | Quality control of prostate 1 H MRSI data |
| Q38531336 | State-of-the-art imaging of prostate cancer |
| Q37738793 | Technological advances in radiation therapy for prostate cancer |
| Q27006744 | The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel |
| Q26849794 | The role of magnetic resonance imaging in the diagnosis and management of prostate cancer |
| Q51666921 | The role of preoperative endo-rectal coil magnetic resonance imaging in predicting surgical difficulty for robotic prostatectomy. |
| Q38263706 | The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol |
| Q40114843 | Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer |
| Q42029183 | Utility of preoperative 3 Tesla pelvic phased-array multiparametric magnetic resonance imaging in prediction of extracapsular extension and seminal vesicle invasion of prostate cancer and its impact on surgical margin status: Experience at a Canadia |
| Q83237479 | Value of multiparametric prostate MRI of the peripheral zone |
| Q87366424 | [Prostate cancer] |
Search more.